中外製薬の業績推移
(単位:百万円)
|
売上高 |
営業利益 |
経常利益 |
純利益 |
売上原価 |
売上総利益 |
株主資本 |
総負債 |
総資産 |
現金及び現金同等物 |
流動市場性有価証券 |
流動資産 |
流動負債 |
利益剰余金 |
営業利益率 |
経常利益率 |
当期利益率 |
自己資本比率 |
営業キャッシュフロー |
投資キャッシュフロー |
財務キャッシュフロー |
営業キャッシュフローマージン |
フリーキャッシュフロー |
ROE |
ROA |
一株あたり利益 |
希薄化後一株あたり利益 |
従業員数 |
2023年12月
|
1,111,367
|
439,174
|
443,821
|
325,472
|
413,306
|
698,061
|
1,625,580
|
306,967
|
1,932,547
|
458,674
|
|
1,366,426
|
288,217
|
|
39.52%
|
39.93%
|
29.29%
|
84.12%
|
409,925
|
-37,290
|
-139,331
|
36.88%
|
372,635
|
21.34%
|
17.12%
|
0.00019783
|
|
7604人
|
2022年12月
|
1,259,726
|
533,309
|
531,166
|
374,429
|
476,251
|
783,475
|
1,424,387
|
445,371
|
1,869,758
|
222,169
|
|
1,336,537
|
423,730
|
|
42.34%
|
42.17%
|
29.72%
|
76.18%
|
243,582
|
-145,465
|
-145,641
|
19.34%
|
98,117
|
28.67%
|
21.97%
|
0.00022764
|
|
7771人
|
2021年12月
|
999,759
|
421,897
|
419,385
|
302,995
|
338,147
|
661,612
|
1,188,017
|
350,677
|
1,538,694
|
267,753
|
|
1,063,661
|
327,422
|
|
42.2%
|
41.95%
|
30.31%
|
77.21%
|
279,626
|
-118,927
|
-107,408
|
27.97%
|
160,699
|
27.95%
|
21.84%
|
0.00018429
|
|
7664人
|
2020年12月
|
786,946
|
301,230
|
298,188
|
214,733
|
273,465
|
513,481
|
980,003
|
255,495
|
1,235,498
|
212,333
|
|
834,906
|
236,070
|
|
38.28%
|
37.89%
|
27.29%
|
79.32%
|
205,035
|
-98,312
|
-99,497
|
26.05%
|
106,723
|
23.42%
|
18.72%
|
0.00013066
|
|
7555人
|
2019年12月
|
686,184
|
210,597
|
207,893
|
157,560
|
266,071
|
420,113
|
853,985
|
204,930
|
1,058,915
|
203,941
|
|
699,680
|
179,268
|
|
30.69%
|
30.3%
|
22.96%
|
80.65%
|
206,641
|
-81,741
|
-66,872
|
30.11%
|
124,900
|
19.57%
|
15.93%
|
0.00009595
|
|
7394人
|
2018年12月
|
579,787
|
124,323
|
121,449
|
92,488
|
262,847
|
316,940
|
756,529
|
163,019
|
919,548
|
146,860
|
|
600,093
|
135,218
|
|
21.44%
|
20.95%
|
15.95%
|
82.27%
|
119,074
|
-74,060
|
-35,014
|
20.54%
|
45,014
|
12.76%
|
10.44%
|
0.00005636
|
|
7432人
|
2017年12月
|
534,199
|
98,934
|
97,031
|
72,713
|
252,900
|
281,299
|
692,897
|
159,576
|
852,473
|
139,074
|
|
|
|
|
18.52%
|
18.16%
|
13.61%
|
81.28%
|
107,623
|
-36,718
|
-29,563
|
20.15%
|
70,905
|
10.87%
|
8.77%
|
0.00004435
|
|
7372人
|
2016年12月
|
491,780
|
76,884
|
74,448
|
53,592
|
244,836
|
246,944
|
645,508
|
160,777
|
806,285
|
95,368
|
|
|
|
|
15.63%
|
15.14%
|
10.9%
|
80.06%
|
38,787
|
-10,107
|
-33,415
|
7.89%
|
28,680
|
8.43%
|
6.73%
|
0.00003271
|
0.00009797
|
7245人
|
2015年12月
|
498,839
|
86,784
|
87,276
|
61,125
|
240,390
|
258,449
|
625,857
|
161,544
|
787,401
|
101,707
|
|
|
|
|
17.4%
|
17.5%
|
12.25%
|
79.48%
|
62,918
|
-45,269
|
-28,467
|
12.61%
|
17,649
|
10.0%
|
8.01%
|
0.000112
|
0.00011179
|
7169人
|
2014年12月
|
461,109
|
75,859
|
76,164
|
50,980
|
217,000
|
244,109
|
596,099
|
143,439
|
739,538
|
114,037
|
|
|
|
|
16.45%
|
16.52%
|
11.06%
|
80.6%
|
37,034
|
-14,351
|
-24,388
|
8.03%
|
22,683
|
9.03%
|
7.1%
|
0.00009353
|
0.00009338
|
7023人
|
2013年12月
|
426,003
|
78,738
|
77,764
|
50,895
|
186,100
|
239,903
|
532,894
|
164,318
|
697,212
|
115,070
|
|
|
|
|
18.48%
|
18.25%
|
11.95%
|
76.43%
|
53,521
|
-13,213
|
-23,169
|
12.56%
|
40,308
|
9.95%
|
7.58%
|
0.00009347
|
0.00009284
|
6872人
|
2012年12月
|
391,220
|
76,413
|
75,406
|
46,052
|
167,726
|
223,494
|
490,074
|
155,251
|
645,325
|
95,445
|
|
|
|
|
19.53%
|
19.27%
|
11.77%
|
75.94%
|
77,542
|
-54,901
|
-22,792
|
19.82%
|
22,641
|
9.7%
|
7.47%
|
0.00008858
|
0.00008854
|
6836人
|
2011年12月
|
373,516
|
62,430
|
63,585
|
35,234
|
157,506
|
216,010
|
459,072
|
128,183
|
587,255
|
94,474
|
|
|
|
|
16.71%
|
17.02%
|
9.43%
|
78.17%
|
69,593
|
-15,135
|
-24,551
|
18.63%
|
54,458
|
7.76%
|
6.43%
|
0.00006475
|
0.00006473
|
6779人
|
2010年12月
|
379,509
|
66,238
|
65,088
|
41,433
|
162,417
|
217,092
|
449,394
|
58,622
|
508,016
|
65,143
|
|
|
|
|
17.45%
|
17.15%
|
10.92%
|
88.46%
|
15,572
|
-20,192
|
-23,054
|
4.1%
|
-4,620
|
|
|
0.00007614
|
0.00007612
|
6709人
|
2009年12月
|
428,947
|
|
90,395
|
56,634
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
21.07%
|
13.2%
|
|
|
|
|
|
|
|
|
0.000104
|
0.00010398
|
6485人
|